Raymond J. Andersen
Corporate Officer/Principal bij University of British Columbia
Actieve functies van Raymond J. Andersen
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| University of British Columbia | Corporate Officer/Principal | 01-01-1977 | - |
Loopbaan van Raymond J. Andersen
Eerdere bekende functies van Raymond J. Andersen
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| ESSA PHARMA INC. | Directeur/Bestuurslid | 11-10-2010 | 31-07-2019 |
| Hoofd Techniek/Wetenschap/O&O | 11-10-2010 | 31-07-2019 | |
| Oprichter | 06-01-2009 | 31-07-2019 | |
| Bedrijfssecretaris | 06-01-2009 | 31-07-2019 | |
Aquinox Pharmaceuticals, Inc.
 Aquinox Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aquinox Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. It discovers and develops targeted therapeutics for inflammation and immuno-oncology. It also focuses on anti-inflammatory product candidates targeting SHIP1, which is a key regulator of an important cellular signaling pathway in immune cells, known as the PI3K pathway. The company was founded by Raymond J. Andersen, David J. Main, Low Fung Mui, Christopher John Ong, and Gerald Krystal on December 26, 2003 and is headquartered in Vancouver, Canada. | Oprichter | 26-12-2003 | - |
Opleiding van Raymond J. Andersen
| University of Alberta | Undergraduate Degree |
| University of California, Berkeley | Graduate Degree |
| University of California San Diego | Doctorate Degree |
Statistieken
Internationaal
| Canada | 5 |
| Verenigde Staten | 3 |
Operationeel
| Founder | 2 |
| Director/Board Member | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
Sectoraal
| Consumer Services | 5 |
| Health Technology | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| ESSA PHARMA INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Aquinox Pharmaceuticals, Inc.
Aquinox Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aquinox Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. It discovers and develops targeted therapeutics for inflammation and immuno-oncology. It also focuses on anti-inflammatory product candidates targeting SHIP1, which is a key regulator of an important cellular signaling pathway in immune cells, known as the PI3K pathway. The company was founded by Raymond J. Andersen, David J. Main, Low Fung Mui, Christopher John Ong, and Gerald Krystal on December 26, 2003 and is headquartered in Vancouver, Canada. | Health Technology |
- Beurs
- Insiders
- Raymond J. Andersen
- Ervaring
